Biopsy Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
NEW YORK, July 16, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Biopsy Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
Biopsy Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
Summary
GlobalData's new report, "Biopsy Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018" provides key data, information and analysis on the global biopsy devices market. The report provides market landscape, competitive landscape and market trends information on the biopsy devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Annualized market revenue data for 2011 and forecast forward for seven years to 2018. Company shares data for 2011.
- Qualitative analysis of key market trends, market drivers, and restraints within biopsy devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include C.R. BARD, Devicor Medical Products, CareFusion Corporation and Hologic.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the biopsy devices globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- What's the next big thing in the biopsy devices market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global biopsy devices market and the factors shaping it.
1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 GlobalData Report Guidance 7
3 Disease Overview - Cancer 8
3.1 Epidemiology 8
4 Biopsy Devices - Overview 9
5 Biopsy Devices - Global Market Characterization 10
5.1 Biopsy Devices Market, Global, Revenue ($m), Forecast, 2011-2018 10
5.2 Biopsy Devices, Market Dynamics 11
5.2.1 Market Drivers 11
5.2.2 Market Restraints 15
6 Biopsy Devices Market, by Country, Revenue ($m), 2011-2018 16
6.1 Biopsy Devices Market, The US, Revenue ($m), 2011-2018 16
6.2 Biopsy Devices Market, Canada, Revenue ($m), 2011-2018 17
6.3 Biopsy Devices Market, The UK, Revenue ($m), 2011-2018 18
6.4 Biopsy Devices Market, Germany, Revenue ($m), 2011-2018 19
6.5 Biopsy Devices Market, France, Revenue ($m), 2011-2018 20
6.6 Biopsy Devices Market, Italy, Revenue ($m), 2011-2018 21
6.7 Biopsy Devices Market, Spain, Revenue ($m), 2011-2018 22
6.8 Biopsy Devices Market, Japan, Revenue ($m), 2011-2018 23
6.9 Biopsy Devices Market, China, Revenue ($m), 2011-2018 24
6.10 Biopsy Devices Market, India, Revenue ($m), 2011-2018 25
6.11 Biopsy Devices Market, Australia, Revenue ($m), 2011-2018 26
6.12 Biopsy Devices Market, Brazil, Revenue ($m), 2011-2018 27
7 Biopsy Devices Market: Strategic Competitive Assessment 28
7.1 Biopsy Devices Market, Global, Company Share (%), 2011 28
7.2 Biopsy Devices, Market Opportunities and Risk Evaluation 29
7.2.1 Opportunities 29
7.3 Biopsy Devices Market, Key Market Participants 30
7.3.1 C.R. Bard 30
7.3.2 Devicor Medical Products, Inc. 31
7.3.3 CareFusion Corporation 32
7.3.4 Hologic, Inc. 33
8 Biopsy Devices Market - Strategic Pipeline Assessment 35
8.1 Biopsy Devices, List Pipeline Products 37
8.2 Biopsy Devices, Key Pipeline Products 38
8.2.1 Aspire Biopsy: Control Medical Technology 38
8.2.2 Aspire Rotational Vacuum-Assisted Biopsy: Control Medical Technology 38
8.2.3 Biopsy Device: Precision Biopsy Llc 38
8.2.4 Endoarterial Biopsy Catheter: Vascular BioSciences 39
8.2.5 Endobronchial Lung Navigation and Biopsy System: Veran Medical Technologies, Inc. 39
8.2.6 Guideliner: Guide-X Ltd. 40
8.2.7 Hunter Biopsy Marker Device: Vascular Solutions, Inc. 40
8.2.8 Minimally Invasive Cutting Instrumentation: C.R. Bard, Inc. 40
8.2.9 Next Generation Fluorescence Based System: SpectraScience, Inc. 41
8.2.10 Radio Frequency Tissue Welding Device: VitruMed Inc. 41
8.2.11 Robopsy System: Robopsy 41
8.2.12 SnapPath Biomarker Testing System: BioMarker Strategies 42
8.2.13 Scobe-E System: Oncoscope, Inc. 42
8.2.14 Verisante Core: Verisante Technology, Inc. 43
8.2.15 Verisante Aura: Verisante Technology, Inc. 43
8.2.16 WavStat - Bladder Cancer: SpectraScience, Inc. 43
8.2.17 WavStat - Esophageal Cancer: SpectraScience, Inc. 44
8.2.18 WavStat - Gastric Cancer: SpectraScience, Inc. 44
8.2.19 WavStat - Inflammatory Bowel Syndrome: SpectraScience, Inc. 45
8.2.20 WavStat - Lung Cancer: SpectraScience, Inc. 45
8.2.21 WavStat - Pancreatic Cancer: SpectraScience, Inc. 45
8.2.22 WavStat - Skin Cancer: SpectraScience, Inc. 46
9 Biopsy Devices Market - Deals Landscape 47
9.1 Biopsy Devices Market, Key Deals, 2007–2011 47
9.1.1 Ums United Medical Acquires Mobile Biopsy, 2011 47
9.1.2 C. R. Bard Acquires SenoRx for $213m, 2010 48
9.1.3 C. R. Bard Acquires Assets from Inrad, 2007 48
9.1.4 iCAD Enters into Distribution Agreement with Hitachi Medical Systems, 2011 49
9.1.5 Abnova Enters into Co-Development Agreement with Clearbridge BioMedics, 2011 49
9.1.6 Ethicon Endo-Surgery Completes Sale of Breast Care Business to Devicor Medical Products, 2010 50
9.1.7 Varian Medical Systems Acquires Pan-Pacific Enterprises, 2007 51
9.1.8 Hologic Acquires Suros Surgical Systems, 2006 51
9.1.9 Hologic Sells Intellectual Property of Mammotest System to Siemens, 2006 52
10 Appendix 53
10.1 Definitions 53
10.1.1 Biopsy Devices 53
10.2 Acronyms 54
10.3 Sources 54
10.4 Research Methodology 55
10.4.1 Secondary Research 55
10.4.2 Primary Research 56
10.4.3 Models 56
10.4.4 Forecasts 56
10.4.5 Expert Panels 56
10.5 GlobalData Consulting 57
10.6 Contact Us 57
10.7 Disclaimer 57
List of Tables
Table 1: Biopsy Devices Market, Global, Revenue ($m), 2011-2018 10
Table 2: Leading Cancer Sites in the Lower Middle Income Economies, 2008 11
Table 3: Percentage of People Aged 65 Years and Above in Total Adult Population, by Country (%), 1980-2050 13
Table 4: National Average Medicare Payment Rate ($), The US, Vacuum-assisted Breast Biopsy vs. Core Needle Breast Biopsy, 2011 14
Table 5: Biopsy Devices Market, The US, Revenue ($m), 2011-2018 16
Table 6: Biopsy Devices Market, Canada, Revenue ($m), 2011-2018 17
Table 7: Biopsy Devices Market, The UK, Revenue ($m), 2011-2018 18
Table 8: Biopsy Devices Market, Germany, Revenue ($m), 2011-2018 19
Table 9: Biopsy Devices Market, France, Revenue ($m), 2011-2018 20
Table 10: Biopsy Devices Market, Italy, Revenue ($m), 2011-2018 21
Table 11: Biopsy Devices Market, Spain, Revenue ($m), 2011-2018 22
Table 12: Biopsy Devices Market, Japan, Revenue ($m), 2011-2018 23
Table 13: Biopsy Devices Market, China, Revenue ($m), 2011-2018 24
Table 14: Biopsy Devices Market, India, Revenue ($m), 2011-2018 25
Table 15: Biopsy Devices Market, Australia, Revenue ($m), 2011-2018 26
Table 16: Biopsy Devices Market, Brazil, Revenue ($m), 2011-2018 27
Table 17: Biopsy Devices Market, Global, Company Share (%), Revenue ($m), 2011 28
Table 18: C.R. Bard, Key Marketed Products 31
Table 19: Devicor Medical Products, Inc., Key Marketed Products 32
Table 20: CareFusion Corporation, Key Marketed Products 33
Table 21: Hologic, Inc., Key Marketed Products 34
Table 22: Biopsy Devices, List of Pipeline Products, 2012 37
Table 23: Aspire Biopsy, Product Status, 2011 38
Table 24: Aspire Rotational Vacuum-Assisted Biopsy, Product Status, 2011 38
Table 25: Biopsy Device, Product Status, 2011 39
Table 26: Endoarterial Biopsy Catheter, Product Status, 2011 39
Table 27: Endobronchial Lung Navigation and Biopsy System, Product Status, 2011 39
Table 28: Guideliner, Product Status, 2011 40
Table 29: Hunter Biopsy Marker Device, Product Status, 2011 40
Table 30: Minimally Invasive Cutting Instrumentation, Product Status, 2011 40
Table 31: Next Generation Fluorescence Based System, Product Status, 2011 41
Table 32: Radio Frequency Tissue Welding Device, Product Status, 2011 41
Table 33: Robopsy System, Product Status, 2011 41
Table 34: SnapPath Biomarker Testing System, Product Status, 2011 42
Table 35: Scobe-E System, Product Status, 2011 42
Table 36: Verisante Core, Product Status, 2011 43
Table 37: Verisante Aura, Product Status, 2011 43
Table 38: WavStat - Bladder Cancer, Product Status, 2011 44
Table 39: WavStat - Esophageal Cancer, Product Status, 2011 44
Table 40: WavStat - Gastric Cancer, Product Status, 2011 44
Table 41: WavStat - Inflammatory Bowel Syndrome, Product Status, 2011 45
Table 42: WavStat - Lung Cancer, Product Status, 2011 45
Table 43: WavStat - Pancreatic Cancer, Product Status, 2011 46
Table 44: WavStat - Skin Cancer, Product Status, 2011 46
Table 45: Biopsy Devices Market, Deals, by Volume, Global, 2006–2011* 47
Table 46: Ums United Medical Acquires Mobile Biopsy, 2011 47
Table 47: C. R. Bard Acquires SenoRx for $213m, 2010 48
Table 48: C. R. Bard Acquires Assets from Inrad, 2007 48
Table 49: iCAD Enters into Distribution Agreement with Hitachi Medical Systems, 2011 49
Table 50: iCAD Enters into Distribution Agreement with Hitachi Medical Systems, 2011 49
Table 51: Ethicon Endo-Surgery Completes Sale of Breast Care Business to Devicor Medical Products, 2010 50
Table 52: Varian Medical Systems Acquires Pan-Pacific Enterprises, 2007 51
Table 53: Hologic Acquires Suros Surgical Systems, 2006 51
Table 54: Hologic Sells Intellectual Property of Mammotest System to Siemens, 2006 52
List of Figures
Figure 1: Biopsy Devices Market, Global, Revenue ($m), 2011-2018 10
Figure 2: Biopsy Devices, Market Dynamics 11
Figure 3: Percentage of People Aged 65 Years and Above in Total Adult Population, by Country (%), 1980-2050 12
Figure 4: Biopsy Devices Market, Needle Biopsy vs. Open Biopsy 13
Figure 5: Biopsy Devices Market, The US, Revenue ($m), 2011-2018 16
Figure 6: Biopsy Devices Market, Canada, Revenue ($m), 2011-2018 17
Figure 7: Biopsy Devices Market, The UK, Revenue ($m), 2011-2018 18
Figure 8: Biopsy Devices Market, Germany, Revenue ($m), 2011-2018 19
Figure 9: Biopsy Devices Market, France, Revenue ($m), 2011-2018 20
Figure 10: Biopsy Devices Market, Italy, Revenue ($m), 2011-2018 21
Figure 11: Biopsy Devices Market, Spain, Revenue ($m), 2011-2018 22
Figure 12: Biopsy Devices Market, Japan, Revenue ($m), 2011-2018 23
Figure 13: Biopsy Devices Market, China, Revenue ($m), 2011-2018 24
Figure 14: Biopsy Devices Market, India, Revenue ($m), 2011-2018 25
Figure 15: Biopsy Devices Market, Australia, Revenue ($m), 2011-2018 26
Figure 16: Biopsy Devices Market, Brazil, Revenue ($m), 2011-2018 27
Figure 17: Biopsy Devices Market, Global, Company Share (%), 2011 28
Figure 18: Biopsy Devices, Market Opportunities and Risk Evaluation, 2012 29
Figure 19: Biopsy Devices Market, Pipeline Assessment, by Development Stage 35
Figure 20: Biopsy Devices Market, Pipeline Assessment, by Unmet Need 36
Companies mentioned
C.R. Bard
Devicor Medical Products, Inc.
CareFusion Corporation
Hologic, Inc.
To order this report: Diagnostics Industry: Biopsy Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
Check our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article